Published in J Virol on May 01, 2006
Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6. J Virol (2006) 2.79
Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid- and heparan sulfate proteoglycan-independent transduction activity. J Virol (2007) 1.60
Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer. Pharm Res (2007) 1.50
Naturally occurring singleton residues in AAV capsid impact vector performance and illustrate structural constraints. Gene Ther (2009) 1.42
AAV's anatomy: roadmap for optimizing vectors for translational success. Curr Gene Ther (2010) 1.27
Epidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6. Nat Med (2010) 1.22
Gangliosides are essential for bovine adeno-associated virus entry. J Virol (2006) 1.17
Proteolytic mapping of the adeno-associated virus capsid. Mol Ther (2006) 1.03
Capsid antibodies to different adeno-associated virus serotypes bind common regions. J Virol (2013) 1.01
Purification of host cell enzymes involved in adeno-associated virus DNA replication. J Virol (2007) 0.96
Large animal models of neurological disorders for gene therapy. ILAR J (2009) 0.95
Molecular characterization of the heparin-dependent transduction domain on the capsid of a novel adeno-associated virus isolate, AAV(VR-942). J Virol (2008) 0.92
Reducing the risk of adeno-associated virus (AAV) vector mobilization with AAV type 5 vectors. J Virol (2009) 0.84
Adeno-associated virus enhances wild-type and oncolytic adenovirus spread. Hum Gene Ther Methods (2013) 0.76
Scalable downstream strategies for purification of recombinant adeno- associated virus vectors in light of the properties. Curr Pharm Biotechnol (2015) 0.75
ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES. Science (1965) 9.77
Nucleotide sequence and organization of the adeno-associated virus 2 genome. J Virol (1983) 7.52
Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics. Proc Natl Acad Sci U S A (1966) 7.35
Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc Natl Acad Sci U S A (1982) 5.73
Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J Virol (1998) 4.71
Identification of a heparin-binding motif on adeno-associated virus type 2 capsids. J Virol (2003) 3.25
Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J Biol Chem (2001) 3.15
Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J Virol (2001) 3.11
Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding. J Virol (2003) 2.93
Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles. J Virol (1997) 2.91
Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3. Virology (1996) 2.26
Adeno-associated virus types 5 and 6 use distinct receptors for cell entry. Hum Gene Ther (2006) 1.50
Cloning and characterization of a bovine adeno-associated virus. J Virol (2004) 1.46
Human cytomegalovirus completely helps adeno-associated virus replication. Virology (1985) 1.39
Transposase-mediated construction of an integrated adeno-associated virus type 5 helper plasmid. Biotechniques (2002) 1.00
Identification of adeno-associated virus contamination in cell and virus stocks by PCR. Biotechniques (2004) 0.99
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol (2009) 9.67
Identification of PDGFR as a receptor for AAV-5 transduction. Nat Med (2003) 2.43
Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology (2005) 2.36
The family Parvoviridae. Arch Virol (2013) 2.12
Structurally mapping the diverse phenotype of adeno-associated virus serotype 4. J Virol (2006) 1.97
Btbd7 regulates epithelial cell dynamics and branching morphogenesis. Science (2010) 1.75
Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndrome. Arthritis Rheum (2009) 1.67
Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics. Proc Natl Acad Sci U S A (2004) 1.64
Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid- and heparan sulfate proteoglycan-independent transduction activity. J Virol (2007) 1.60
AAV transcytosis through barrier epithelia and endothelium. Mol Ther (2005) 1.60
Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography. Hum Gene Ther (2002) 1.60
Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors. J Neurosci (2005) 1.56
Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material. Hum Gene Ther (2010) 1.51
Structure of adeno-associated virus serotype 5. J Virol (2004) 1.50
Structure of adeno-associated virus type 4. J Virol (2005) 1.47
Poxvirus Bioinformatics Resource Center: a comprehensive Poxviridae informational and analytical resource. Nucleic Acids Res (2005) 1.47
Cloning and characterization of a bovine adeno-associated virus. J Virol (2004) 1.46
Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry peak sorting algorithm. J Chromatogr A (2007) 1.42
Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction. Proc Natl Acad Sci U S A (2012) 1.38
Cloning of an avian adeno-associated virus (AAAV) and generation of recombinant AAAV particles. J Virol (2003) 1.37
Performance evaluation of existing de novo sequencing algorithms. J Proteome Res (2006) 1.36
Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjögren's syndrome. Hum Gene Ther (2003) 1.28
Secreted and transmembrane mucins inhibit gene transfer with AAV4 more efficiently than AAV5. J Biol Chem (2002) 1.27
Salivary glands as a potential gene transfer target for gene therapeutics of some monogenetic endocrine disorders. J Endocrinol (2005) 1.23
Tyrosine kinase receptor Axl enhances entry of Zaire ebolavirus without direct interactions with the viral glycoprotein. Virology (2011) 1.22
Epidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6. Nat Med (2010) 1.22
Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors. J Virol (2009) 1.20
Production, purification, crystallization and preliminary X-ray structural studies of adeno-associated virus serotype 5. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 1.17
Gangliosides are essential for bovine adeno-associated virus entry. J Virol (2006) 1.17
Toxicity and biodistribution of a first-generation recombinant adenoviral vector, encoding aquaporin-1, after retroductal delivery to a single rat submandibular gland. Hum Gene Ther (2006) 1.17
Neural network prediction of peptide separation in strong anion exchange chromatography. Bioinformatics (2006) 1.17
The parvovirus capsid odyssey: from the cell surface to the nucleus. Trends Microbiol (2008) 1.15
Development of a gene transfer-based treatment for radiation-induced salivary hypofunction. Oral Oncol (2009) 1.15
Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transfer. Arthritis Res Ther (2010) 1.13
Adeno-associated virus type 5: transduction efficiency and cell-type specificity in the primate retina. Hum Gene Ther (2003) 1.12
Coordinated control of connexin 26 and connexin 30 at the regulatory and functional level in the inner ear. Proc Natl Acad Sci U S A (2008) 1.11
Extended transgene expression from a nonintegrating adenoviral vector containing retroviral elements. Mol Ther (2008) 1.10
Adeno-associated virus serotype 2-mediated gene transfer to the parotid glands of nonhuman primates. Hum Gene Ther (2007) 1.10
Transient detection of E1-containing adenovirus in saliva after the delivery of a first-generation adenoviral vector to human parotid gland. J Gene Med (2010) 1.09
PKA/PrKX activity is a modulator of AAV/adenovirus interaction. EMBO J (2003) 1.08
IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer. Lab Invest (2010) 1.07
Natural variation among human adenoviruses: genome sequence and annotation of human adenovirus serotype 1. J Gen Virol (2004) 1.05
A novel bovine virus efficiently transduces inner ear neuroepithelial cells. Mol Ther (2005) 1.05
Complementation analysis of the dales collection of vaccinia virus temperature-sensitive mutants. Virology (2003) 1.03
Immune responses following salivary gland administration of recombinant adeno-associated virus serotype 2 vectors. J Gene Med (2005) 1.02
Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS). Mol Cell Proteomics (2013) 1.01
Capsid antibodies to different adeno-associated virus serotypes bind common regions. J Virol (2013) 1.01
Multi-dimensional liquid chromatography in proteomics--a review. Anal Chim Acta (2010) 1.00
Identification of adeno-associated virus contamination in cell and virus stocks by PCR. Biotechniques (2004) 0.99
Transfer of the AQP1 cDNA for the correction of radiation-induced salivary hypofunction. Biochim Biophys Acta (2005) 0.99
Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 4. Virology (2003) 0.98
BAAV transcytosis requires an interaction with beta-1-4 linked- glucosamine and gp96. PLoS One (2010) 0.94
Recombinant adeno-associated virus serotype 2 vectors mediate stable interleukin 10 secretion from salivary glands into the bloodstream. Hum Gene Ther (2002) 0.93
Local expression of tumor necrosis factor-receptor 1:immunoglobulin G can induce salivary gland dysfunction in a murine model of Sjögren's syndrome. Arthritis Res Ther (2009) 0.93
Examining the cross-reactivity and neutralization mechanisms of a panel of mAbs against adeno-associated virus serotypes 1 and 5. J Gen Virol (2011) 0.93
Structural insights into adeno-associated virus serotype 5. J Virol (2013) 0.92
Molecular characterization of the heparin-dependent transduction domain on the capsid of a novel adeno-associated virus isolate, AAV(VR-942). J Virol (2008) 0.92
Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome. Arthritis Res Ther (2012) 0.92
Long-term transduction of miniature pig parotid glands using serotype 2 adeno-associated viral vectors. J Gene Med (2009) 0.91
BAAV mediated GJB2 gene transfer restores gap junction coupling in cochlear organotypic cultures from deaf Cx26Sox10Cre mice. PLoS One (2011) 0.90
Re-engineering primary epithelial cells from rhesus monkey parotid glands for use in developing an artificial salivary gland. Tissue Eng (2006) 0.90
Gene therapy using IL-27 ameliorates Sjögren's syndrome-like autoimmune exocrinopathy. Arthritis Res Ther (2012) 0.90
GeneOrder3.0: software for comparing the order of genes in pairs of small bacterial genomes. BMC Bioinformatics (2004) 0.86
Mechanisms of translational regulation by a human eIF5-mimic protein. Nucleic Acids Res (2011) 0.86
Location of immunization and interferon-γ are central to induction of salivary gland dysfunction in Ro60 peptide immunized model of Sjögren's syndrome. PLoS One (2011) 0.86
Viral vector tropism for supporting cells in the developing murine cochlea. Hear Res (2011) 0.85
Intranasal administration of adeno-associated virus type 12 (AAV12) leads to transduction of the nasal epithelia and can initiate transgene-specific immune response. Mol Ther (2011) 0.85
Adeno-associated virus type 5 reduces learning deficits and restores glutamate receptor subunit levels in MPS VII mice CNS. Mol Ther (2007) 0.84
Sites in the AAV5 capsid tolerant to deletions and tandem duplications. Arch Biochem Biophys (2010) 0.83
Interactive analysis of systems biology molecular expression data. BMC Syst Biol (2008) 0.83
Adeno-associated virus type 2 Rep78 inhibition of PKA and PRKX: fine mapping and analysis of mechanism. J Virol (2002) 0.83
Effect of soluble ICAM-1 on a Sjögren's syndrome-like phenotype in NOD mice is disease stage dependent. PLoS One (2011) 0.82
Intrinsic subtype-associated changes in the plasma proteome in breast cancer. Proteomics Clin Appl (2009) 0.81
Transduction, tropism, and biodistribution of AAV vectors in the lacrimal gland. Invest Ophthalmol Vis Sci (2011) 0.81
Association of bone morphogenetic protein 6 with exocrine gland dysfunction in patients with Sjögren's syndrome and in mice. Arthritis Rheum (2013) 0.80
Recovery of radiation-induced dry eye and corneal damage by pretreatment with adenoviral vector-mediated transfer of erythropoietin to the salivary glands in mice. Hum Gene Ther (2013) 0.80
Oral vaccination with adeno-associated virus vectors expressing the Neu oncogene inhibits the growth of murine breast cancer. Mol Ther (2013) 0.79
Local administration of soluble CD40:Fc to the salivary glands of non-obese diabetic mice does not ameliorate autoimmune inflammation. PLoS One (2012) 0.79
Transduction of rat pancreatic islets with pseudotyped adeno-associated virus vectors. Virol J (2009) 0.78
Glucagon-like peptide-1 gene therapy. Exp Diabetes Res (2011) 0.78
Assessment of the safety and biodistribution of a regulated AAV2 gene transfer vector after delivery to murine submandibular glands. Toxicol Sci (2011) 0.78
Sustained exendin-4 secretion through gene therapy targeting salivary glands in two different rodent models of obesity/type 2 diabetes. PLoS One (2012) 0.78
Mutation in the platelet-derived growth factor receptor alpha inhibits adeno-associated virus type 5 transduction. Virology (2012) 0.78
Different osteogenic potentials of recombinant human BMP-6 adeno-associated virus and adenovirus in two rat strains. Tissue Eng (2006) 0.77
Identification of contaminating adenovirus type 1 in the ATCC reference strain of respiratory syncytial virus A2 (VR-1302). Virus Res (2003) 0.77
A large, consistent plasma proteomics data set from prospectively collected breast cancer patient and healthy volunteer samples. J Transl Med (2011) 0.77
Recombinant adeno-associated viral vector types 4 and 5. Preparation and application for CNS gene transfer. Methods Mol Med (2003) 0.75